A roadmap for effective treatment of COVID-19

Researchers from the US Food and Drug Administration have reviewed the available scientific literature on COVID-19 and systematically outlined key immunological factors underlying COVID-19 disease severity. Based on these factors, the researchers indicate a range of approved and available drugs, as well as drugs currently under clinical investigation, as possible candidates for treatment.